1W1E - JenaLib

Theoretical Model (Jmol Viewer)

Title :   MITOCHONDRIAL HUMAN THIOREDOXIN REDUCTASE IN COMPLEX WITH THIOREDOXIN

Authors :   W. Brandt, L. A. Wessjohann

Date :   21 Jun 04 (Deposition) - 19 Jan 05 (Release) - 28 Oct 05 (Revision)

Method :   THEORETICAL MODEL

Resolution :   NOT APPLICABLE

Chains :   Theor. Model : A,B,C

Keywords :   Thioredoxin Reductase, Thioredoxin, Fad, Nadp, Oxidoreductase, Selenocysteine, Redox-Active Center, Flavoprotein, Direct Protein Sequencing, Cse, Electron Transport (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   W. Brandt, L. Wessjohann
The Functional Role Of Selenocysteine (Sec) In The Catalysis Mechanism Of Large Thioredoxin Reductases: Proposition Of A Swapping Catalytic Triad Including A Sec-His-Glu State
To Be Published
PubMed: search
(for further references see the PDB file header)

Molecule 1 - THIOREDOXIN REDUCTASE
	Cellular Location	:	MITOCHONDRIAL
	Chains	:	A, B
	EC Number	:	1.8.1.9
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Other Details	:	HOMODIMER CONTAINS NADP+FAD/SUBUNIT
	Synonym	:	TR3, TR-BETA, SELENOPROTEIN Z, SELZ
	Tissue	:	PLACENTA, BRAIN, CERVICAL CARCINOMA

Molecule 2 - THIOREDOXIN
	Chains	:	C
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Synonym	:	ATL-DERIVED FACTOR, ADF, SURFACE ASSOCIATED SULPHYDRYL PROTEIN, SASP


Theoretical Model	:

Summary Information (see also Sequences/Alignments below)

Theoretical Model (3, 6)

No.	Name	Count	Type	Full Name
1	CSE	2	Mod. Amino Acid	SELENOCYSTEINE
2	FAD	2	Ligand/Ion	FLAVIN-ADENINE DINUCLEOTIDE
3	NDP	2	Ligand/Ion	NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDEPHOSPHATE

(no "Site" information available for 1W1E)

Theoretical Model

No.	Residues
1	A:61	-	A:66
2	B:61	-	B:66
3	C:32	-	C:35

Theoretical Model

No.	Residues
1	Ile A:226	-	Pro A:227
2	Pro A:431	-	Pro A:432
3	His A:472	-	Pro A:473
4	Ile B:226	-	Pro B:227
5	Pro B:431	-	Pro B:432
6	His B:472	-	Pro B:473
7	Met C:74	-	Pro C:75

Theoretical Model (3, 6)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_051778	A	66	S	TRXR2_HUMAN	Polymorphism	5748469	A/B	A	41	S
2	UniProt	VAR_051779	S	299	R	TRXR2_HUMAN	Polymorphism	5992495	A/B	S	274	R
3	UniProt	VAR_051780	I	370	T	TRXR2_HUMAN	Polymorphism	1139793	A/B	I	345	T

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Theoretical Model (3, 4)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	THIOREDOXIN_2	PS51352	Thioredoxin domain profile.	THIO_HUMAN	1-105	1	C:1-105
2	THIOREDOXIN_1	PS00194	Thioredoxin family active site.	THIO_HUMAN	24-42	1	C:24-42
3	PYRIDINE_REDOX_1	PS00076	Pyridine nucleotide-disulphide oxidoreductases class-I active site.	TRXR2_HUMAN	83-93	2	A:58-68 B:58-68

Theoretical Model (21, 37)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000374517	1a	ENSE00001463713	chr9:113018920-113018692	229	THIO_HUMAN	1-8	8	1	C:1-8	8
1.2	ENST00000374517	2	ENSE00000806083	chr9:113013742-113013638	105	THIO_HUMAN	9-43	35	1	C:9-43	35
1.3	ENST00000374517	3	ENSE00000806082	chr9:113013159-113013100	60	THIO_HUMAN	44-63	20	1	C:44-63	20
1.4b	ENST00000374517	4b	ENSE00000806081	chr9:113007123-113007058	66	THIO_HUMAN	64-85	22	1	C:64-85	22
1.5b	ENST00000374517	5b	ENSE00001945358	chr9:113006499-113006091	409	THIO_HUMAN	86-105	20	1	C:86-105	20

2.1b	ENST00000400521	1b	ENSE00001543323	chr22:19929333-19929224	110	TRXR2_HUMAN	1-35	35	0	-	-
2.4a	ENST00000400521	4a	ENSE00001344032	chr22:19918621-19918553	69	TRXR2_HUMAN	35-58	24	2	A:11-33 B:11-33	23 23
2.5	ENST00000400521	5	ENSE00001712467	chr22:19907122-19907066	57	TRXR2_HUMAN	58-77	20	2	A:33-52 B:33-52	20 20
2.6	ENST00000400521	6	ENSE00001649161	chr22:19906527-19906383	145	TRXR2_HUMAN	77-125	49	2	A:52-100 B:52-100	49 49
2.7b	ENST00000400521	7b	ENSE00001803882	chr22:19905740-19905666	75	TRXR2_HUMAN	125-150	26	2	A:100-125 B:100-125	26 26
2.8b	ENST00000400521	8b	ENSE00001700288	chr22:19903366-19903288	79	TRXR2_HUMAN	150-176	27	2	A:125-151 B:125-151	27 27
2.9a	ENST00000400521	9a	ENSE00001772418	chr22:19902799-19902737	63	TRXR2_HUMAN	177-197	21	2	A:152-172 B:152-172	21 21
2.10a	ENST00000400521	10a	ENSE00001639097	chr22:19898970-19898900	71	TRXR2_HUMAN	198-221	24	2	A:173-196 B:173-196	24 24
2.12	ENST00000400521	12	ENSE00001703902	chr22:19886591-19886572	20	TRXR2_HUMAN	221-228	8	2	A:196-203 B:196-203	8 8
2.13b	ENST00000400521	13b	ENSE00001689972	chr22:19885653-19885562	92	TRXR2_HUMAN	228-258	31	2	A:203-233 B:203-233	31 31
2.14	ENST00000400521	14	ENSE00001301692	chr22:19883104-19882930	175	TRXR2_HUMAN	259-317	59	2	A:234-292 B:234-292	59 59
2.16b	ENST00000400521	16b	ENSE00001325883	chr22:19870984-19870848	137	TRXR2_HUMAN	317-362	46	2	A:292-337 B:292-337	46 46
2.17f	ENST00000400521	17f	ENSE00001305592	chr22:19868240-19868145	96	TRXR2_HUMAN	363-394	32	2	A:338-369 B:338-369	32 32
2.18	ENST00000400521	18	ENSE00001298332	chr22:19867794-19867702	93	TRXR2_HUMAN	395-425	31	2	A:370-400 B:370-400	31 31
2.19	ENST00000400521	19	ENSE00001319621	chr22:19865960-19865889	72	TRXR2_HUMAN	426-449	24	2	A:401-424 B:401-424	24 24
2.20	ENST00000400521	20	ENSE00001323000	chr22:19865710-19865613	98	TRXR2_HUMAN	450-482	33	2	A:425-457 B:425-457	33 33
2.21b	ENST00000400521	21b	ENSE00001302661	chr22:19864757-19864563	195	TRXR2_HUMAN	482-524	43	2	A:457-499 B:457-499	43 43
2.21j	ENST00000400521	21j	ENSE00001543330	chr22:19863330-19863045	286	TRXR2_HUMAN	-	0	0	-	-

Theoretical Model

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:489
 aligned with TRXR2_HUMAN | Q9NNW7 from UniProtKB/Swiss-Prot  Length:524

    Alignment length:489
                                    45        55        65        75        85        95       105       115       125       135       145       155       165       175       185       195       205       215       225       235       245       255       265       275       285       295       305       315       325       335       345       355       365       375       385       395       405       415       425       435       445       455       465       475       485       495       505       515         
          TRXR2_HUMAN    36 GQRDYDLLVVGGGSGGLACAKEAAQLGRKVAVVDYVEPSPQGTRWGLGGTCVNVGCIPKKLMHQAALLGGLIQDAPNYGWEVAQPVPHDWRKMAEAVQNHVKSLNWGHRVQLQDRKVKYFNIKASFVDEHTVCGVAKGGKEILLSADHIIIATGGRPRYPTHIEGALEYGITSDDIFWLKESPGKTLVVGASYVALECAGFLTGIGLDTTIMMRSIPLRGFDQQMSSMVIEHMASHGTRFLRGCAPSRVRRLPDGQLQVTWEDSTTGKEDTGTFDTVLWAIGRVPDTRSLNLEKAGVDTSPDTQKILVDSREATSVPHIYAIGDVVEGRPELTPIAIMAGRLLVQRLFGGSSDLMDYDNVPTTVFTPLEYGCVGLSEEEAVARHGQEHVEVYHAHYKPLEFTVAGRDASQCYVKMVCLREPPQLVLGLHFLGPNAGEVTQGFALGIKCGASYAQVMRTVGIHPTCSEEVVKLRISKRSGLDPTVTGCUG 524
               SCOP domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....eeeeee..hhhhhhhhhhhhh....eee...............hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh.........hhhhhhhhhhhhhhhhhhhhhhhhhhh..ee..eeeeeee..eeeeee......eeeeeeeee...eee.......hhhhhh.hhhhhh........eeee..hhhhhhhhhhhhhhhh.eeee.........hhhhhhhhhhhhhhh..ee....eeeeeeee...eeeeeeee...eee......eee....eee.....hhhhhh......................eee..........hhhhhhhhhhhhhhhhh............eeee....eeeeee.hhhhhhhhhh...eeeeeee..hhhhhhhh......eeeeeee......eeeeeeee.hhhhhhhhhhhhhhh..hhhhhhhh......hhhhhhhh................. Sec.struct. author
                 SAPs(SNPs) ------------------------------S----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------R----------------------------------------------------------------------T---------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (2) -----------------------------------------------PYRIDINE_RE----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
           Transcript 2 (1) Exon 2.4a  PDB: A:11-33------------------Exon 2.6  PDB: A:52-100 UniProt: 77-125          ------------------------Exon 2.8b  PDB: A:125-151  Exon 2.9a            Exon 2.10a              ------Exon 2.13b  PDB: A:203-233     Exon 2.14  PDB: A:234-292 UniProt: 259-317                 ---------------------------------------------Exon 2.17f  PDB: A:338-369      Exon 2.18  PDB: A:370-400      Exon 2.19  PDB: A:401-42Exon 2.20  PDB: A:425-457        ------------------------------------------ Transcript 2 (1)
           Transcript 2 (2) ----------------------Exon 2.5            -----------------------------------------------Exon 2.7b  PDB: A:100-125 ----------------------------------------------------------------------2.12    ----------------------------------------------------------------------------------------Exon 2.16b  PDB: A:292-337 UniProt: 317-362   -----------------------------------------------------------------------------------------------------------------------Exon 2.21b  PDB: A:457-499 UniProt: 482-524 Transcript 2 (2)
                 1w1e A  11 GQRDYDLLVVGGGSGGLACAKEAAQLGRKVAVVDYVEPSPQGTRWGLGGTCVNVGCIPKKLMHQAALLGGLIQDAPNYGWEVAQPVPHDWRKMAEAVQNHVKSLNWGHRVQLQDRKVKYFNIKASFVDEHTVCGVAKGGKEILLSADHIIIATGGRPRYPTHIEGALEYGITSDDIFWLKESPGKTLVVGASYVALECAGFLTGIGLDTTIMMRSIPLRGFDQQMSSMVIEHMASHGTRFLRGCAPSRVRRLPDGQLQVTWEDSTTGKEDTGTFDTVLWAIGRVPDTRSLNLEKAGVDTSPDTQKILVDSREATSVPHIYAIGDVVEGRPELTPIAIMAGRLLVQRLFGGSSDLMDYDNVPTTVFTPLEYGCVGLSEEEAVARHGQEHVEVYHAHYKPLEFTVAGRDASQCYVKMVCLREPPQLVLGLHFLGPNAGEVTQGFALGIKCGASYAQVMRTVGIHPTCSEEVVKLRISKRSGLDPTVTGCcG 499
                                    20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       | 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 498-CSE

Chain B from PDB  Type:PROTEIN  Length:489
 aligned with TRXR2_HUMAN | Q9NNW7 from UniProtKB/Swiss-Prot  Length:524

    Alignment length:489
                                    45        55        65        75        85        95       105       115       125       135       145       155       165       175       185       195       205       215       225       235       245       255       265       275       285       295       305       315       325       335       345       355       365       375       385       395       405       415       425       435       445       455       465       475       485       495       505       515         
          TRXR2_HUMAN    36 GQRDYDLLVVGGGSGGLACAKEAAQLGRKVAVVDYVEPSPQGTRWGLGGTCVNVGCIPKKLMHQAALLGGLIQDAPNYGWEVAQPVPHDWRKMAEAVQNHVKSLNWGHRVQLQDRKVKYFNIKASFVDEHTVCGVAKGGKEILLSADHIIIATGGRPRYPTHIEGALEYGITSDDIFWLKESPGKTLVVGASYVALECAGFLTGIGLDTTIMMRSIPLRGFDQQMSSMVIEHMASHGTRFLRGCAPSRVRRLPDGQLQVTWEDSTTGKEDTGTFDTVLWAIGRVPDTRSLNLEKAGVDTSPDTQKILVDSREATSVPHIYAIGDVVEGRPELTPIAIMAGRLLVQRLFGGSSDLMDYDNVPTTVFTPLEYGCVGLSEEEAVARHGQEHVEVYHAHYKPLEFTVAGRDASQCYVKMVCLREPPQLVLGLHFLGPNAGEVTQGFALGIKCGASYAQVMRTVGIHPTCSEEVVKLRISKRSGLDPTVTGCUG 524
               SCOP domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....eeeeee..hhhhhhhhhhhhh....eee...............hhhhhhh.hhhhhhhhhhhhhhhhhhhhhhhh.........hhhhhhhhhhhhhhhhhhhhhhhhhhh..ee..eeeeeee..eeeeee......eeeeeeeee....ee.............eehhhhh........eeee..hhhhhhhhhhhhhhhh.eeeee...hhhhhhhhhhhhhhhhhhhh..eeee..eeeeeeee...eeeeeeee...eee......eeee...ee......hhhhhh......................eee.hhh......hhhhhhhhhhhhhhhhh............eeee....eeeeee.hhhhhhhhhh...eeeeeeee.hhhhhhhh.....eeeeeeee......eeeeeeee.hhhhhhhhhhhhhhh..hhhhhhhh.....hhhhhhhhh................. Sec.struct. author
                 SAPs(SNPs) ------------------------------S----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------R----------------------------------------------------------------------T---------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (2) -----------------------------------------------PYRIDINE_RE----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
           Transcript 2 (1) Exon 2.4a  PDB: B:11-33------------------Exon 2.6  PDB: B:52-100 UniProt: 77-125          ------------------------Exon 2.8b  PDB: B:125-151  Exon 2.9a            Exon 2.10a              ------Exon 2.13b  PDB: B:203-233     Exon 2.14  PDB: B:234-292 UniProt: 259-317                 ---------------------------------------------Exon 2.17f  PDB: B:338-369      Exon 2.18  PDB: B:370-400      Exon 2.19  PDB: B:401-42Exon 2.20  PDB: B:425-457        ------------------------------------------ Transcript 2 (1)
           Transcript 2 (2) ----------------------Exon 2.5            -----------------------------------------------Exon 2.7b  PDB: B:100-125 ----------------------------------------------------------------------2.12    ----------------------------------------------------------------------------------------Exon 2.16b  PDB: B:292-337 UniProt: 317-362   -----------------------------------------------------------------------------------------------------------------------Exon 2.21b  PDB: B:457-499 UniProt: 482-524 Transcript 2 (2)
                 1w1e B  11 GQRDYDLLVVGGGSGGLACAKEAAQLGRKVAVVDYVEPSPQGTRWGLGGTCVNVGCIPKKLMHQAALLGGLIQDAPNYGWEVAQPVPHDWRKMAEAVQNHVKSLNWGHRVQLQDRKVKYFNIKASFVDEHTVCGVAKGGKEILLSADHIIIATGGRPRYPTHIEGALEYGITSDDIFWLKESPGKTLVVGASYVALECAGFLTGIGLDTTIMMRSIPLRGFDQQMSSMVIEHMASHGTRFLRGCAPSRVRRLPDGQLQVTWEDSTTGKEDTGTFDTVLWAIGRVPDTRSLNLEKAGVDTSPDTQKILVDSREATSVPHIYAIGDVVEGRPELTPIAIMAGRLLVQRLFGGSSDLMDYDNVPTTVFTPLEYGCVGLSEEEAVARHGQEHVEVYHAHYKPLEFTVAGRDASQCYVKMVCLREPPQLVLGLHFLGPNAGEVTQGFALGIKCGASYAQVMRTVGIHPTCSEEVVKLRISKRSGLDPTVTGCcG 499
                                    20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490       | 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 498-CSE

Chain C from PDB  Type:PROTEIN  Length:105
 aligned with THIO_HUMAN | P10599 from UniProtKB/Swiss-Prot  Length:105

    Alignment length:105
                                    10        20        30        40        50        60        70        80        90       100     
           THIO_HUMAN     1 MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCMPTFQFFKKGQKVGEFSGANKEKLEATINELV 105
               SCOP domains --------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .eee..hhhhhhhhhhhhh..eeeee.....hhhhh.hhhhhhhh......eeeee.....hhhhhhhh......eeeeee..eeeeeee..hhhhhhhhhhhhh Sec.struct. author
                 SAPs(SNPs) --------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) THIOREDOXIN_2  PDB: C:1-105 UniProt: 1-105                                                                PROSITE (1)
                PROSITE (2) -----------------------THIOREDOXIN_1      --------------------------------------------------------------- PROSITE (2)
               Transcript 1 1.1a    Exon 1.2  PDB: C:9-43 UniProt: 9-43Exon 1.3            Exon 1.4b  PDB: C:64-8Exon 1.5b            Transcript 1
                 1w1e C   1 MVKQIESKTAFQEALDAAGDKLVVVDFSATWCGPCKMIKPFFHSLSEKYSNVIFLEVDVDDCQDVASECEVKCMPTFQFFKKGQKVGEFSGANKEKLEATINELV 105
                                    10        20        30        40        50        60        70        80        90       100

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

(no "SCOP Domain" information available for 1W1E)

(no "CATH Domain" information available for 1W1E)

(no "Pfam Domain" information available for 1W1E)

Theoretical Model(hide GO term definitions)

Chain A,B (TRXR2_HUMAN | Q9NNW7)

molecular function
	GO:0050660	flavin adenine dinucleotide binding	Interacting selectively and non-covalently with FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.
	GO:0016491	oxidoreductase activity	Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
	GO:0016668	oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor	Catalysis of an oxidation-reduction (redox) reaction in which a sulfur-containing group acts as a hydrogen or electron donor and reduces NAD or NADP.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004791	thioredoxin-disulfide reductase activity	Catalysis of the reaction: NADP(+) + thioredoxin = H(+) + NADPH + thioredoxin disulfide.
biological process
	GO:0045454	cell redox homeostasis	Any process that maintains the redox environment of a cell or compartment within a cell.
	GO:0098869	cellular oxidant detoxification	Any process carried out at the cellular level that reduces or removes the toxicity superoxide radicals or hydrogen peroxide.
	GO:0055114	oxidation-reduction process	A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
	GO:0000305	response to oxygen radical	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxygen radical stimulus. An oxygen radical is any oxygen species that carries a free electron; examples include hydroxyl radicals and the superoxide anion.
	GO:0000302	response to reactive oxygen species	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.
cellular component
	GO:0005759	mitochondrial matrix	The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation.
	GO:0005739	mitochondrion	A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.

Chain C (THIO_HUMAN | P10599)

molecular function
	GO:0016671	oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor	Catalysis of an oxidation-reduction (redox) reaction in which a sulfur-containing group acts as a hydrogen or electron donor and reduces disulfide.
	GO:0015037	peptide disulfide oxidoreductase activity	Catalysis of the reaction: a peptide with reduced sulfide groups = a peptide with oxidized disulfide bonds.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0015035	protein disulfide oxidoreductase activity	Catalysis of the reaction: a protein with reduced sulfide groups = a protein with oxidized disulfide bonds.
biological process
	GO:0032148	activation of protein kinase B activity	Any process that initiates the activity of the inactive enzyme protein kinase B.
	GO:0008283	cell proliferation	The multiplication or reproduction of cells, resulting in the expansion of a cell population.
	GO:0045454	cell redox homeostasis	Any process that maintains the redox environment of a cell or compartment within a cell.
	GO:0007267	cell-cell signaling	Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
	GO:0006662	glycerol ether metabolic process	The chemical reactions and pathways involving glycerol ethers, any anhydride formed between two organic hydroxy compounds, one of which is glycerol.
	GO:0006928	movement of cell or subcellular component	The directed, self-propelled movement of a cell or subcellular component without the involvement of an external agent such as a transporter or a pore.
	GO:1903206	negative regulation of hydrogen peroxide-induced cell death	Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced cell death.
	GO:0046826	negative regulation of protein export from nucleus	Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of proteins from the nucleus into the cytoplasm.
	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0015949	nucleobase-containing small molecule interconversion	The chemical reactions and pathways by which a nucleobase, nucleoside or nucleotide small molecule is synthesized from another nucleobase, nucleoside or nucleotide small molecule.
	GO:0055114	oxidation-reduction process	A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
	GO:0043388	positive regulation of DNA binding	Any process that increases the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
	GO:0033138	positive regulation of peptidyl-serine phosphorylation	Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
	GO:0051897	positive regulation of protein kinase B signaling	Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
	GO:0006457	protein folding	The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure.
	GO:0030091	protein repair	The process of restoring a protein to its original state after damage by such things as oxidation or spontaneous decomposition of residues.
	GO:0033158	regulation of protein import into nucleus, translocation	Any process that modulates the vectorial transfer of a protein from the cytoplasm into the nucleus, across the nuclear membrane.
	GO:0006355	regulation of transcription, DNA-templated	Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0009314	response to radiation	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.
	GO:0000302	response to reactive oxygen species	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
	GO:0000103	sulfate assimilation	The pathways by which inorganic sulfate is processed and incorporated into sulfated compounds.
	GO:0006351	transcription, DNA-templated	The cellular synthesis of RNA on a template of DNA.
cellular component
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005739	mitochondrion	A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
	GO:0005654	nucleoplasm	That part of the nuclear content other than the chromosomes or the nucleolus.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

Theoretical Model
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		CSE	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		FAD	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NDP	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
(no "Sites" information available for 1w1e)

	Cis Peptide Bonds
		His A:472 - Pro A:473	[ RasMol ]
		His B:472 - Pro B:473	[ RasMol ]
		Ile A:226 - Pro A:227	[ RasMol ]
		Ile B:226 - Pro B:227	[ RasMol ]
		Met C:74 - Pro C:75	[ RasMol ]
		Pro A:431 - Pro A:432	[ RasMol ]
		Pro B:431 - Pro B:432	[ RasMol ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Theoretical Model PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	1w1e
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	THIO_HUMAN \| P10599
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt
	TRXR2_HUMAN \| Q9NNW7
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	1.8.1.9
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	(no 'MIM ID' available)
		Disease Information	:	OMIM

Access by GenAge ID
	0016
		Age Related Information	:	GenAge
	0138
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	THIO_HUMAN \| P10599
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)
	TRXR2_HUMAN \| Q9NNW7
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

1aiu	HUMAN THIOREDOXIN (D60N MUTANT, REDUCED FORM)
1auc	HUMAN THIOREDOXIN (OXIDIZED WITH DIAMIDE)
1cqg	HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN REF-1 (RESIDUES 59 - 71 OF THE P50 SUBUNIT OF NFKB), NMR, 31 STRUCTURES
1cqh	HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN REF-1 (RESIDUES 59 - 71 OF THE P50 SUBUNIT OF NFKB), NMR, MINIMIZED AVERAGE STRUCTURE
1ert	HUMAN THIOREDOXIN (REDUCED FORM)
1eru	HUMAN THIOREDOXIN (OXIDIZED FORM)
1erv	HUMAN THIOREDOXIN MUTANT WITH CYS 73 REPLACED BY SER (REDUCED FORM)
1erw	HUMAN THIOREDOXIN DOUBLE MUTANT WITH CYS 32 REPLACED BY SER AND CYS 35 REPLACED BY SER
1m7t	SOLUTION STRUCTURE AND DYNAMICS OF THE HUMAN -ESCHERICHIACOLI THIOREDOXIN CHIMERA: INSIGHTS INTO THERMODYNAMICSTABILITY
1mdi	HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN MUTANT HUMAN THIOREDOXIN AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN NFKB
1mdj	HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN NFKB (RESIDUES 56-68 OF THE P50 SUBUNIT OF NFKB)
1mdk	HIGH RESOLUTION SOLUTION NMR STRUCTURE OF MIXED DISULFIDE INTERMEDIATE BETWEEN HUMAN THIOREDOXIN (C35A, C62A, C69A, C73A) MUTANT AND A 13 RESIDUE PEPTIDE COMPRISING ITS TARGET SITE IN HUMAN NFKB (RESIDUES 56-68 OF THE P50 SUBUNIT OF NFKB)
1trs	THIOREDOXIN MUTANT WITH CYS 62 REPLACED BY ALA, CYS 69 REPLACED BY ALA, CYS 73 REPLACED BY ALA (C62A,C69A,C73A) (OXIDIZED ) (NMR, MINIMIZED AVERAGE STRUCTURE)
1tru	THIOREDOXIN MUTANT WITH CYS 62 REPLACED BY ALA, CYS 69 REPLACED BY ALA, CYS 73 REPLACED BY ALA (C62A,C69A,C73A) (OXIDIZED ) (NMR, 40 STRUCTURES)
1trv	THIOREDOXIN MUTANT WITH CYS 62 REPLACED BY ALA, CYS 69 REPLACED BY ALA, CYS 73 REPLACED BY ALA (C62A,C69A,C73A) (REDUCED ) (NMR, 40 STRUCTURES)
1trw	THIOREDOXIN MUTANT WITH CYS 62 REPLACED BY ALA, CYS 69 REPLACED BY ALA, CYS 73 REPLACED BY ALA (C62A,C69A,C73A) (REDUCED ) (NMR, MINIMIZED AVERAGE STRUCTURE)
1w1c	HUMAN CYTOPLASMIC THIOREDOXIN REDUCTASE (TXN1) IN COMPLEX WITH THIOREDOXIN (TRX)
3trx	THIOREDOXIN (REDUCED FORM)
4trx	THIOREDOXIN (REDUCED FORM)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (3, 6)

Sites (0, 0)

SS Bonds (3, 3)

Cis Peptide Bonds (7, 7)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (3, 6)

PROSITE Motifs (3, 4)

Exons (21, 37)

Sequences/Alignments

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (41, 46)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File